Determination of High Mobility Group A1 (HMGA1) Expression in Hepatocellular Carcinoma: A Potential Prognostic Marker
- 1 October 2005
- journal article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 50 (10), 1764-1770
- https://doi.org/10.1007/s10620-005-2934-9
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase‐2 expression in prostate cancer cellsThe Prostate, 2004
- High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasmsThe Esophagus, 2003
- Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial CellsMolecular and Cellular Biology, 2001
- Hepatocellular carcinomaJournal of Hepatology, 2000
- Effects of Epidermal Growth Factor and Estrogen on the Regulation of the HMG-I/Y Gene in Human Mammary Epithelial Cell LinesDNA and Cell Biology, 1997
- Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-CNature, 1995
- Expression and cDNA Cloning of Human HMGI-C PhosphoproteinBiochemical and Biophysical Research Communications, 1994
- Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elementsCell, 1993
- Chromosomal localization of the murine gene and two related sequences encoding high-mobility-group I and Y proteinsGenomics, 1992
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976